ketamine has been researched along with Cholangitis, Sclerosing in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knooihuizen, SAI | 1 |
| Aday, A | 1 |
| Lee, WM | 1 |
| Turkish, A | 1 |
| Luo, JJ | 1 |
| Lefkowitch, JH | 1 |
2 other studies available for ketamine and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19.
Topics: Anesthetics, Dissociative; Biliary Tract; Cholangitis, Sclerosing; Conscious Sedation; COVID-19; Fem | 2021 |
Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis.
Topics: Administration, Inhalation; Anesthetics, Dissociative; Biliary Tract Diseases; Biopsy; Cholangitis, | 2013 |